Felix Keller
Overview
Explore the profile of Felix Keller including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
610
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Aktas G, Keller F, Siwy J, Latosinska A, Mischak H, Mayor J, et al.
Sci Rep
. 2025 Jan;
15(1):898.
PMID: 39762268
Treatment of severely injured patients represents a major challenge, in part due to the unpredictable risk of major adverse events, including death. Preemptive personalized treatment aimed at preventing these events...
2.
Keller F, Denicolo S, Leierer J, Kruus M, Heinzel A, Kammer M, et al.
Kidney Blood Press Res
. 2024 Nov;
49(1):1013-1025.
PMID: 39510044
Introduction: Diabetic kidney disease (DKD) is a common cause of chronic kidney disease with around 25-40% of patients with diabetes being affected. The course of DKD is variable, and estimated...
3.
Siwy J, Keller F, Banasik M, Peters B, Dudoignon E, Mebazaa A, et al.
Biomedicines
. 2024 Sep;
12(9).
PMID: 39335603
Background/objectives: Survival prospects following SARS-CoV-2 infection may extend beyond the acute phase, influenced by various factors including age, health conditions, and infection severity; however, this topic has not been studied...
4.
Plattner C, Sallaberger S, Bohn J, Zavadil C, Keller F, Soleiman A, et al.
Clin Kidney J
. 2024 May;
17(5):sfae109.
PMID: 38726211
Background: The development of chronic kidney disease (CKD) in about 20%-40% of patients with type 2 diabetes (T2D) aggravates cardiovascular morbidity and mortality. Pathophysiology is of increasing relevance for individual...
5.
Denicolo S, Reinstadler V, Keller F, Thoni S, Eder S, Heerspink H, et al.
Diabetologia
. 2024 Apr;
67(7):1283-1294.
PMID: 38647650
Aims/hypothesis: Non-adherence to medication is a frequent barrier in the treatment of patients with type 2 diabetes mellitus, potentially limiting the effectiveness of evidence-based treatments. Previous studies have mostly relied...
6.
Lauder L, Siwy J, Mavrogeorgis E, Keller F, Kunz M, Wachter A, et al.
Hypertension
. 2024 Apr;
81(6):1374-1382.
PMID: 38572643
Background: Catheter-based renal denervation (RDN) reduces blood pressure in hypertension. Urinary peptides are associated with cardiovascular and renal disease and provide prognostic information. We aimed to investigate the effect of...
7.
Moller A, Thoni S, Keller F, Sharifli S, Rasmussen D, Genovese F, et al.
Biomedicines
. 2023 Nov;
11(11).
PMID: 38002084
We investigated for the first time the effect of combination therapy of renin-angiotensin system inhibition (RASi) and sodium-glucose co-transporter-2 inhibitors (SGLT2is) on endotrophin (ETP), a pro-fibrotic signaling molecule reflecting collagen...
8.
Rahmanzade R, Pfaff E, Banan R, Sievers P, Suwala A, Hinz F, et al.
Acta Neuropathol
. 2023 Sep;
146(6):853-856.
PMID: 37776353
No abstract available.
9.
Jaimes Campos M, Andujar I, Keller F, Mayer G, Rossing P, Staessen J, et al.
Pharmaceuticals (Basel)
. 2023 Sep;
16(9).
PMID: 37765106
(1) Background: Kidney and cardiovascular diseases are responsible for a large fraction of population morbidity and mortality. Early, targeted, personalized intervention represents the ideal approach to cope with this challenge....
10.
Keller F, Beige J, Siwy J, Mebazaa A, An D, Mischak H, et al.
J Transl Med
. 2023 Sep;
21(1):663.
PMID: 37741989
Background: There is evidence of pre-established vulnerability in individuals that increases the risk of their progression to severe disease or death, although the mechanisms causing this are still not fully...